Malnutrition  >>  Monofer (iron isomaltoside 1000)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Monofer (iron isomaltoside 1000) / Pharmacosmos
NCT01017614 / 2009-012544-16: Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

Completed
3
350
Europe, RoW
Monofer, Iron Sulphate
Pharmacosmos A/S, Max Neeman International
Inflammatory Bowel Disease
07/12
08/12
NCT02172001 / 2014-001518-25: A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo

Withdrawn
3
0
US
Iron isomaltoside 1000, Natrium Chloride 0,9%
Pharmacosmos A/S
Iron Deficiency Anemia
03/15
 
NCT02130063: IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose

Completed
3
511
US
iron isomaltoside 1000 (Monofer®), iron sucrose (Venofer®)
Pharmacosmos A/S, BioStata, ClinStar, LLC, Laboratory Corporation of America
Iron Deficiency Anaemia
08/15
08/15

Download Options